| abstract |
A novel 4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepine derivative represented by the following formula (I) or a pharmaceutically acceptable salt of the derivative. They are useful as a therapeutic or preventive agent for night pollakisuria and/or diabetes insipidus. |